Press Release

<< Back
Nov 01, 2017

Cross Country Healthcare Announces Third Quarter 2017 Financial Results

BOCA RATON, Fla., Nov. 1, 2017 /PRNewswire/ -- Cross Country Healthcare, Inc. (the "Company") (Nasdaq: CCRN) today announced financial results for the third quarter ended September 30, 2017.

Cross Country Healthcare, Inc. (PRNewsfoto/Cross Country Healthcare, Inc.)

FINANCIAL HIGHLIGHTS:

Amounts are in thousands, except percent and per share data

Q3 2017

Variance
Q3 2017 vs.
Q3 2016

Variance
Q3 2017 vs.
Q2 2017

Revenue

$

228,488

6

%

9

%

Gross profit margin*

26.5

%

(60)

bps

(50)

bps

Net income attributable to common shareholders

$

6,723

(52)

%

39

%

Diluted EPS

$

0.19

$

(0.03)

$

0.06

Adjusted EBITDA*

$

13,769

5

%

27

%

Adjusted EPS*

$

0.23

$

(0.01)

$

0.07

* Refer to accompanying tables and discussion of Non-GAAP financial measures below.

"This was a good quarter that sets us up for an improved financial performance in 2018," said William J. Grubbs, President and Chief Executive Officer. "We have recovered from the lower operating margins earlier in the year and are growing into the investments made in recruiters and candidate attraction. I am particularly pleased that we are on track for another record year of winning new MSPs that should support our current momentum."

Third quarter consolidated revenue was $228.5 million, an increase of 6% year-over-year and 9% sequentially. On a pro forma basis, revenue was down 5% year-over-year and 3% sequentially. Severe weather forced the closure of the Company's travel nurse and allied office in Florida, as well as several branches, resulting in a relatively minor negative impact to revenue and profitability for the third quarter and, due to the nature of the Company's business, it is expected to result in a more significant impact for the fourth quarter. Consolidated gross profit margin was 26.5%, down 60 basis points year-over-year and down 50 basis points sequentially, driven predominantly by the impact of the Advantage RN acquisition. Net income attributable to common shareholders was $6.7 million compared to $14.1 million in the prior year, which included a gain on derivative liability of $7.1 million. Diluted EPS was $0.19 per share compared to $0.22 per share in the prior year. Adjusted EBITDA was $13.8 million or 6.0% of revenue, as compared with $13.1 million or 6.1% of revenue in the prior year. Adjusted EPS was $0.23 in the current quarter as compared to $0.24 in the prior year and $0.16 in the prior quarter.

For the nine months ended September 30, 2017, consolidated revenue was $645.4 million, an increase of 6% year-over-year. Consolidated gross profit margin was 26.4%, down 50 basis points year-over-year. Adjusted EBITDA was $31.1 million or 4.8% of revenue, as compared with $32.7 million or 5.4% of revenue in the prior year. Net income attributable to common shareholders was $9.6 million, compared to net income of $15.9 million in the prior year, which included a $20.0 million gain on derivative liability. On a diluted per share basis, net income attributable to common shareholders was $0.24, compared to a net loss of $0.04, which excludes the impact of the gain on derivate liability related to the Convertible Notes. Adjusted EPS was $0.44 compared to $0.49 in the prior year.

Quarterly Business Segment Highlights

Nurse and Allied Staffing

Revenue from Nurse and Allied Staffing was $200.5 million, an increase of 7% year-over-year and 11% sequentially. The year-over-year increase in segment revenue was predominantly due to the Advantage RN acquisition. Contribution income in this segment was $20.7 million, up from $19.5 million in the prior year. Average field FTEs increased to 7,706 from 6,954 in the prior year. Revenue per FTE per day was $283 compared to $292 in the prior year, primarily reflecting a change in the mix of business.

Physician Staffing

Revenue from Physician Staffing was $24.9 million, a decrease of 1% year-over-year and an increase of 1% sequentially, with both being driven by changes in volume. Contribution income was $1.3 million, down from $2.4 million in the prior year. Total days filled were 15,777 as compared with 16,639 in the prior year, with declines in physician specialties partly offset by growth in advanced practices. Revenue per day filled was $1,562 as compared with $1,576 in the prior year, representing the impact of the shift in mix from growth in advanced practices, which generally have a lower daily bill rate.

Other Human Capital Management Services

Revenue from Other Human Capital Management Services was $3.1 million, a decrease of 5% year-over-year and 15% sequentially. Segment contribution income was essentially breakeven for the current quarter compared to a loss of $0.2 million in the prior year.

Cash Flow and Balance Sheet Highlights

Cash flow provided by operating activities for the quarter was $3.2 million and $28.7 million for the year-to-date period. At September 30, 2017, the Company had $10.8 million in cash and cash equivalents and a $100.0 million term loan outstanding. There were no borrowings drawn on its $115.0 million revolving credit facility, and $21.6 million of letters of credit outstanding, leaving $93.4 million available for borrowings under the revolving credit facility.

Outlook for Fourth Quarter 2017

Q4 2017 Range

Year-over-Year

Sequential

Change

Change




Revenue

$223 million - $228 million

0% - 2%

(2)% - 0%




Gross profit margin

26.3% - 26.8%

40 - 90 bps

(20) - 30 bps




Adjusted EBITDA

$13 million - $14 million

8% - 17%

(6)% - 2%




Adjusted EPS

$0.18 - $0.20

$(0.02) - $0.00

$(0.05) - $(0.03)

The estimates above are based on current management expectations and, as such, are forward-looking and actual results may differ materially. This guidance reflects an estimated negative impact on revenue from weather events of approximately $4 million. The above ranges do not include the potential impact of any future divestitures, mergers, acquisitions or other business combinations, any impairment charges or valuation allowances, any acquisition-related measurement period adjustments, changes in debt structure, or any material legal or restructuring charges. See accompanying Non-GAAP financial measures and tables below.

INVITATION TO CONFERENCE CALL

The Company will hold its quarterly conference call on Thursday, November 2, 2017, at 9:00 A.M. Eastern Time to discuss its third quarter 2017 financial results. This call will be webcast live and can be accessed at the Company's website at www.crosscountryhealthcare.com or by dialing 800-857-6331 from anywhere in the U.S. or by dialing 517-623-4781 from non-U.S. locations - Passcode: Cross Country. A replay of the webcast will be available from November 2nd through November 16th at the Company's website and a replay of the conference call will be available by telephone by calling 800-570-8799 from anywhere in the U.S. or 203-369-3294 from non-U.S. locations - Passcode: 2017.

ABOUT CROSS COUNTRY HEALTHCARE

Cross Country Healthcare is a national leader in providing innovative healthcare workforce solutions and staffing services. Our solutions leverage our nearly 40 years of expertise and insight to assist clients in solving complex labor-related challenges while maintaining high quality outcomes. We are dedicated to recruiting and placing highly qualified healthcare professionals in virtually every specialty and area of expertise. Our diverse client base includes both clinical and nonclinical settings, servicing acute care hospitals, physician practice groups, outpatient and ambulatory-care centers, nursing facilities, both public schools and charter schools, rehabilitation and sports medicine clinics, government facilities, and homecare. Through our national staffing teams and network of 80 office locations, we are able to place clinicians on travel and per diem assignments, local short-term contracts and permanent positions. We are a market leader in providing flexible workforce management solutions, which include managed services programs (MSP), internal resource pool consulting and development, electronic medical record (EMR) transition staffing, recruitment process outsourcing, predictive modeling, and other outsourcing and consultative services. In addition, we provide both retained and contingent placement services for healthcare executives, physicians, and other healthcare professionals.

Copies of this and other news releases as well as additional information about Cross Country Healthcare can be obtained online at www.crosscountryhealthcare.com. Shareholders and prospective investors can also register to automatically receive the Company's press releases, SEC filings and other notices by e-mail.

NON-GAAP FINANCIAL MEASURES

This press release and accompanying financial statement tables reference non-GAAP financial measures. Such non-GAAP financial measures are provided as additional information and should not be considered substitutes for, or superior to, financial measures calculated in accordance with U.S. GAAP.  Such non-GAAP financial measures are provided for consistency and comparability to prior year results; furthermore, management believes they are useful to investors when evaluating the Company's performance as they exclude certain items that management believes are not indicative of the Company's operating performance. Pro forma measures, if applicable, are adjusted to include the results of our acquisitions, and exclude the results of divestments, as if the transactions occurred in the beginning of the periods mentioned.]Such non-GAAP financial measures may differ materially from the non-GAAP financial measures used by other companies. The financial statement tables that accompany this press release include a reconciliation of each non-GAAP financial measure to the most directly comparable U.S. GAAP financial measure and a more detailed discussion of each financial measure; as such, the financial statement tables should be read in conjunction with the presentation of these non-GAAP financial measures.

FORWARD LOOKING STATEMENT

In addition to historical information, this press release contains statements relating to our future results (including certain projections and business trends) that are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and are subject to the "safe harbor" created by those sections. Forward-looking statements consist of statements that are predictive in nature, depend upon or refer to future events. Words such as "expects", "anticipates", "intends", "plans", "believes", "estimates", "suggests", "appears", "seeks", "will", and variations of such words and similar expressions are intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results and performance to be materially different from any future results or performance expressed or implied by these forward-looking statements. These factors include, but are not limited to, the following: our ability to attract and retain qualified nurses, physicians and other healthcare personnel, costs and availability of short-term housing for our travel healthcare professionals, demand for the healthcare services we provide, both nationally and in the regions in which we operate, the functioning of our information systems, the effect of cyber security risks and cyber incidents on our business, the effect of existing or future government regulation and federal and state legislative and enforcement initiatives on our business, our clients' ability to pay us for our services, our ability to successfully implement our acquisition and development strategies, including our ability to successfully integrate acquired businesses and realize synergies from such acquisitions, the effect of liabilities and other claims asserted against us, the effect of competition in the markets we serve, our ability to successfully defend the Company, its subsidiaries, and its officers and directors on the merits of any lawsuit or determine its potential liability, if any, and other factors set forth in Item 1A. "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2016, and our other Securities and Exchange Commission filings made prior to the date hereof.

Although we believe that these statements are based upon reasonable assumptions, we cannot guarantee future results and readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's opinions only as of the date of this press release. There can be no assurance that (i) we have correctly measured or identified all of the factors affecting our business or the extent of these factors' likely impact, (ii) the available information with respect to these factors on which such analysis is based is complete or accurate, (iii) such analysis is correct or (iv) our strategy, which is based in part on this analysis, will be successful. The Company undertakes no obligation to update or revise forward-looking statements. All references to "we", "us", "our", or "Cross Country" in this press release mean Cross Country Healthcare, Inc. and its subsidiaries.

 


Cross Country Healthcare, Inc.

Consolidated Statements of Operations

(Unaudited, amounts in thousands, except per share data)











Three Months Ended

Nine Months Ended

September 30,

September 30,

June 30,

September 30,

September 30,

2017

2016

2017

2017

2016



Revenue from services

$

228,488

$

214,988

$

209,313

$

645,374

$

611,014

Operating expenses:










Direct operating expenses

168,008

156,778

152,785

475,091

446,912

Selling, general and administrative expenses

47,346

45,922

46,600

141,182

133,530

Bad debt expense

433

19

326

1,082

496

Depreciation and amortization

2,849

2,092

2,285

7,325

6,969

Acquisition-related contingent consideration (a)

(605)

237

281

(54)

707

Acquisition and integration costs (b)

1,366

—

587

1,953

—

Restructuring costs (c)

724

611

—

724

611

Impairment charges (d)

—

—

—

—

24,311

Total operating expenses

220,121

205,659

202,864

627,303

613,536

Income (loss) from operations

8,367

9,329

6,449

18,071

(2,522)

Other expenses (income):










Interest expense

1,221

1,435

535

2,975

4,678

Gain on derivative liability (e)

—

(7,105)

—

(1,581)

(19,970)

Loss on early extinguishment of debt (f)

—

—

—

4,969

1,568

Other income, net

(57)

(92)

(59)

(116)

(143)

Income before income taxes

7,203

15,091

5,973

11,824

11,345

Income tax expense (benefit)

159

802

753

1,278

(5,035)

Consolidated net income

7,044

14,289

5,220

10,546

16,380

Less: Net income attributable to noncontrolling interest in subsidiary

321

223

370

983

529

Net income attributable to common shareholders

$

6,723

$

14,066

$

4,850

$

9,563

$

15,851










Net income per share attributable to common shareholders - Basic

$

0.19

$

0.44

$

0.14

$

0.28

$

0.49










Net income (loss) per share attributable to common shareholders - Diluted

$

0.19

$

0.22

$

0.13

$

0.24

$

(0.04)










Weighted average common shares outstanding:










Basic

35,748

32,221

35,651

34,768

32,088

Diluted (g)

36,036

36,255

36,021

36,179

36,215


 

Cross Country Healthcare, Inc.

Reconciliation of Non-GAAP Financial Measures

(Unaudited, amounts in thousands, except per share data)

Three Months Ended

Nine Months Ended

September 30,

September 30,

June 30,

September 30,

September 30,

2017

2016

2017

2017

2016

Adjusted EBITDA: (h)










Net income attributable to common shareholders

$

6,723

$

14,066

$

4,850

$

9,563

$

15,851

Depreciation and amortization

2,849

2,092

2,285

7,325

6,969

Interest expense

1,221

1,435

535

2,975

4,678

Income tax expense (benefit)

159

802

753

1,278

(5,035)

Acquisition-related contingent consideration (a)

(605)

237

281

(54)

707

Acquisition and integration costs (b)

1,366

—

587

1,953

—

Restructuring costs (c)

724

611

—

724

611

Impairment charges (d)

—

—

—

—

24,311

Gain on derivative liability (e)

—

(7,105)

—

(1,581)

(19,970)

Loss on early extinguishment of debt (f)

—

—

—

4,969

1,568

Other income, net

(57)

(92)

(59)

(116)

(143)

Equity compensation

1,068

847

1,278

3,083

2,614

Net income attributable to noncontrolling interest in
subsidiary

321

223

370

983

529

Adjusted EBITDA (h)

$

13,769

$

13,116

$

10,880

$

31,102

$

32,690










Adjusted EPS: (i)










Numerator:










Net income attributable to common shareholders

$

6,723

$

14,066

$

4,850

$

9,563

$

15,851

Non-GAAP adjustments - pretax:










Acquisition-related contingent consideration (a)

(605)

237

281

(54)

707

Acquisition and integration costs (b)

1,366

—

587

1,953

—

Restructuring costs (c)

724

611

—

724

611

Impairment charges (d)

—

—

—

—

24,311

Gain on derivative liability (e)

—

(7,105)

—

(1,581)

(19,970)

Loss on early extinguishment of debt (f)

—

—

—

4,969

1,568

Tax impact of non-GAAP adjustments (j)

—

—

—

—

(7,036)

Adjusted net income attributable to common shareholders - non-GAAP

$

8,208

$

7,809

$

5,718

$

15,574

$

16,042










Denominator:










Weighted average common shares - basic, GAAP

35,748

32,221

35,651

34,767

32,088

Dilutive impact of share-based payments

288

512

370

444

606

Adjusted weighted average common shares - diluted, non-GAAP

36,036

32,733

36,021

35,211

32,694










Reconciliation: (i)










Diluted EPS, GAAP

$

0.19

$

0.22

$

0.13

$

0.24

$

(0.04)

Non-GAAP adjustments - pretax:










Acquisition-related contingent consideration (a)

(0.02)

0.01

0.01

—

0.02

Acquisition and integration costs (b)

0.04

—

0.02

0.06

—

Restructuring costs (c)

0.02

0.02

—

0.02

0.02

Impairment charges (d)

—

—

—

—

0.74

Gain on derivative liability (e)

—

(0.22)

—

(0.05)

(0.61)

Loss on early extinguishment of debt (f)

—

—

—

0.15

0.05

Tax impact of non-GAAP adjustments (j)

—

—

—

—

(0.22)

 Adjustment for change in dilutive shares

—

0.21

—

0.02

0.53

Adjusted EPS, non-GAAP (i)

$

0.23

$

0.24

$

0.16

$

0.44

$

0.49

 

 

Cross Country Healthcare, Inc.

Consolidated Balance Sheets

(Unaudited, amounts in thousands)

September 30,

December 31,

2017

2016



Assets



Current assets:



Cash and cash equivalents

$

10,765

$

20,630

Accounts receivable, net

181,608

173,620

Prepaid expenses

5,142

6,126

Insurance recovery receivable

2,813

3,037

Other current assets

1,654

2,198

Total current assets

201,982

205,611

Property and equipment, net

14,075

12,818

Goodwill, net

123,244

79,648

Trade names, indefinite-lived

35,402

35,402

Other intangible assets, net

62,763

36,835

Other non-current assets

19,190

18,064

Total assets

$

456,656

$

388,378



Liabilities and Stockholders' Equity



Current liabilities:



Accounts payable and accrued expenses

$

55,034

$

58,837

Accrued employee compensation and benefits

32,039

33,243

Other current liabilities

7,146

5,012

Total current liabilities

94,219

97,092

Long-term debt and capital lease obligations

95,331

84,760

Non-current deferred tax liabilities

14,763

13,154

Long-term accrued claims

30,695

28,870

Contingent consideration

4,618

5,301

Other long-term liabilities

7,682

7,399

Total liabilities

247,308

236,576



Commitments and contingencies








Stockholders' equity:



Common stock

4

3

Additional paid-in capital

304,957

256,570

Accumulated other comprehensive loss

(1,198)

(1,241)

Accumulated deficit

(95,061)

(104,089)

Total Cross Country Healthcare, Inc. stockholders' equity

208,702

151,243

Noncontrolling interest in subsidiary

646

559

Total stockholders' equity

209,348

151,802

Total liabilities and stockholders' equity

$

456,656

$

388,378

 

 

Cross Country Healthcare, Inc.

Segment Data (k)

(Unaudited, amounts in thousands)

Three Months Ended

% Change Fav/(Unfav)

September 30,

% of

September 30,

% of

June 30,

% of

Year-over-


2017

Total

2016

Total

2017

Total

Year

Sequential











Revenue from services:











Nurse and Allied Staffing

$

200,492

88

%

$

186,623

87

%

$

180,927

86

%

7

%

11

%

Physician Staffing

24,871

11

%

25,090

12

%

24,720

12

%

(1)

%

1

%

Other Human Capital Management
Services

3,125

1

%

3,275

1

%

3,666

2

%

(5)

%

(15)

%

$

228,488

100

%

$

214,988

100

%

$

209,313

100

%

6

%

9

%











Contribution income: (l)











Nurse and Allied Staffing

$

20,663


$

19,472


$

18,141


6

%

14

%

Physician Staffing

1,340


2,400


2,047


(44)

%

(35)%

Other Human Capital Management Services

(1)


(154)


241


99

%

(100)

%

22,002


21,718


20,429


1

%

8

%











Unallocated corporate overhead (m)

9,301


9,449


10,827


2

%

14

%

Depreciation and amortization

2,849


2,092


2,285


(36)

%

(25)

%

Acquisition-related contingent consideration (a)

(605)


237


281


355

%

315

%

Acquisition and integration costs (b)

1,366


—


587


(100)

%

(133)

%

Restructuring costs (c)

724


611


—


(18)

%

(100)

%

Income from operations

$

8,367


$

9,329


$

6,449


(10)

%

30

%

























Nine Months Ended

% Change Fav/(Unfav)




September 30,

% of

September 30,

% of

Year-over-
Year




2017

Total

2016

Total

















Revenue from services:











Nurse and Allied Staffing

$

564,527

87

%

$

527,436

86

%

7

%




Physician Staffing

71,055

11

%

73,470

12

%

(3)

%




Other Human Capital Management Services

9,792

2

%

10,108

2

%

(3)

%





$

645,374

100

%

$

611,014

100

%

6

%

















Contribution income: (l)











Nurse and Allied Staffing

$

54,426


$

53,877


1

%




Physician Staffing

4,207


6,003


(30)

%




Other Human Capital Management Services

(200)


(196)


(2)

%





58,433


59,684


(2)

%






























Unallocated corporate overhead (m)

30,414


29,608


(3)

%




Depreciation and amortization

7,325


6,969


(5)

%




Acquisition-related contingent consideration (a)

(54)


707


108

%




Acquisition and integration costs (b)

1,953


—


(100)

%




Restructuring costs (c)

724


611


(18)

%




Impairment charges (d)

—


24,311


100

%




Income (loss) from operations

$

18,071


$

(2,522)


817

%

















 

 

Cross Country Healthcare, Inc.

Other Financial Data

(Unaudited)

Three Months Ended

Nine Months Ended

September 30,

September 30,

June 30,

September 30,

September 30,

2017

2016

2017

2017

2016











Net cash provided by operating activities (in
thousands)

$

3,180


$

19,402


$

24,115


$

28,705

$

32,269













Consolidated gross profit margin (n)

26.5

%

27.1

%

27.0

%

26.4

%

26.9

%











Nurse and Allied Staffing statistical data:











FTEs (o)

7,706


6,954


7,155


7,355

6,885

Average Nurse and Allied Staffing revenue per FTE per day (p)

$

283


$

292


$

278


$

281

$

280













Physician Staffing statistical data:











Days filled (q)

15,777


16,639


15,220


46,033

47,961

Revenue per day filled (r)

$

1,562


$

1,576


$

1,557


$

1,570

$

1,542


 

(a)

Acquisition-related contingent consideration represents the fair value and accretion adjustments to the contingent consideration liabilities for the Mediscan acquisition that closed on October 30, 2015 and the US Resources Healthcare acquisition that closed on December 1, 2016.

(b)

Acquisition and integration costs are primarily related to legal and advisory fees for the Advantage RN, LLC acquisition that closed effective July 1, 2017.

(c)

Restructuring costs related to severance and lease consolidations incurred as part of our separate and discrete cost savings initiative.

(d) 

The nine months ended September 30, 2016 includes non-cash impairment charges of $24.3 million ($17.3 million after taxes) related to the Physician Staffing reporting unit.

(e) 

Gain on derivative liability represents the change in the fair value of embedded features of our Convertible Notes up until their repayment.

(f) 

Loss on early extinguishment of debt for the nine months ended September 30, 2017 is related to the Company's settlement of its convertible notes on March 17, 2017. Loss on early extinguishment of debt for the nine months ended September 30, 2016 relates to the write-off of unamortized debt discount and issuance costs as well as transaction fees and expenses related to the extinguishment of the Company's subordinated term loan.

(g) 

When applying the if-converted method to our Convertible Notes, 3,521,126 shares were included in diluted weighted average shares for the three and nine months ended September 30, 2016. For the nine months ended September 30, 2017, there were 967,342 shares included in diluted weighted average shares.

(h) 

Adjusted EBITDA, a non-GAAP (Generally Accepted Accounting Principles) financial measure, is defined as net income attributable to common shareholders before depreciation and amortization, interest expense, income tax expense (benefit), acquisition-related contingent consideration, acquisition and integration costs, restructuring costs, impairment charges, gain on derivative liability, loss on early extinguishment of debt, other income, net, equity compensation, and includes net income attributable to noncontrolling interest in subsidiary. Adjusted EBITDA should not be considered a measure of financial performance under GAAP. Management presents Adjusted EBITDA because it believes that Adjusted EBITDA is a useful supplement to net income attributable to common shareholders as an indicator of operating performance. Management uses Adjusted EBITDA for planning purposes and as one performance measure in its incentive programs for certain members of its management team. Adjusted EBITDA, as defined, closely matches the operating measure typically used in the Company's credit facilities in calculating various ratios. Adjusted EBITDA Margin is calculated by dividing Adjusted EBITDA by the Company's consolidated revenue.

(i) 

Adjusted EPS, a non-GAAP financial measure, is defined as net income (loss) attributable to common shareholders per diluted share before the diluted EPS impact of acquisition-related contingent consideration, acquisition and integration costs, restructuring costs, impairment charges, gain on
derivative liability, and loss on early extinguishment of debt. Adjusted EPS should not be considered a measure of financial performance under GAAP.  Management presents Adjusted EPS because it believes that Adjusted EPS is a useful supplement to its reported EPS as an indicator of operating performance. Management uses Adjusted EPS as one performance measure in its annual cash incentive program for certain members of its management team. Management believes it provides a more useful comparison of the Company's underlying business performance from period to period and is more representative of the future earnings capacity of the Company.

(j) 

Tax impact on the non-GAAP items is related to the impairment charges on indefinite-lived intangible assets of the Physician Staffing business for the nine months ended September 30, 2016. There is no tax impact on the other items due to the Company's full valuation allowance for all reported periods.

(k) 

Segment data provided is in accordance with the Segment Reporting Topic of the FASB ASC.

(l) 

Contribution income is defined as income or loss from operations before depreciation and amortization, acquisition-related contingent consideration, acquisition and integration costs, restructuring costs, impairment charges, and corporate expenses not specifically identified to a reporting segment. Contribution income is a financial measure used by management when assessing segment performance.

(m) 

Unallocated corporate overhead includes corporate compensation and benefits, and general and administrative expenses including rent and utilities, computer supplies and expenses, insurance, professional expenses, corporate-wide projects (initiatives), and public company expense.

(n) 

Gross profit is defined as revenue from services less direct operating expenses. The Company's gross profit excludes allocated depreciation and amortization expense. Gross profit margin is calculated by dividing gross profit by revenue from services.

(o) 

FTEs represent the average number of Nurse and Allied Staffing contract personnel on a full-time equivalent basis.

(p) 

Average revenue per FTE per day is calculated by dividing the Nurse and Allied Staffing revenue by the number of days worked in the respective periods. Nurse and Allied Staffing revenue also includes revenue from the permanent placement of nurses.

(q) 

Days filled is calculated by dividing the total hours invoiced during the period by 8 hours. This method does not reflect the impact of revenue generated from permanent placements, reimbursed expenses, discounts and allowances, and the impact from accruals and adjustments recorded for financial statement purposes.

(r) 

Revenue per day filled is calculated by dividing revenue invoiced by days filled for the period presented.

 

Cross Country Healthcare, Inc.
William J. Grubbs, 561-237-6202
President & Chief Executive Officer
wgrubbs@crosscountry.com

View original content with multimedia:http://www.prnewswire.com/news-releases/cross-country-healthcare-announces-third-quarter-2017-financial-results-300547798.html

SOURCE Cross Country Healthcare, Inc.

News Provided by Acquire Media

Reach out to us to learn about what we have to offer     Contact Us

© 2024 Cross Country Healthcare
Human Rights Policy | Code of Conduct and Business Ethics Policy | Privacy Policy